pI: 9.1894 |
Length (AA): 443 |
MW (Da): 48926 |
Paralog Number:
1
Signal peptide: Y | GPI Anchor: | Predicted trans-membrane segments: 1
Targets have been classified into druggability groups (DG) according to their druggability score in network driven prioritizations. DGs range from 1 to 5; the higher the group number, the higher the chance of the target to be druggable
Modbase 3D models:
PDB Structures:
Upregulation Percent | Ranking | Stage | Dataset |
---|---|---|---|
Mid 40-60% percentile | Procyclic, Bloodstream Form. | Siegel TN |
Siegel TN | Genome-wide analysis of mRNA abundance in two life-cycle stages of Trypanosoma brucei and identification of splicing and polyadenylation sites. |
Ortholog group members (OG5_127709)
Species | Accession | Gene Product |
---|---|---|
Arabidopsis thaliana | AT3G04080 | apyrase 1 |
Arabidopsis thaliana | AT5G18280 | apyrase 2 |
Candida albicans | CaO19.7394 | guanosine diphosphatase |
Caenorhabditis elegans | CELE_K08H10.4 | Protein UDA-1 |
Drosophila melanogaster | Dmel_CG3059 | CG3059 gene product from transcript CG3059-RD |
Homo sapiens | 957 | ectonucleoside triphosphate diphosphohydrolase 5 |
Homo sapiens | ENSG00000197586 | ectonucleoside triphosphate diphosphohydrolase 6 (putative) |
Leishmania braziliensis | LbrM.15.0030 | ATP diphosphohydrolase |
Leishmania braziliensis | LbrM.10.0170 | nucleoside phosphatase, putative,guanosine diphosphatase, putative |
Leishmania donovani | LdBPK_150030.1 | ATP diphosphohydrolase |
Leishmania donovani | LdBPK_100150.1 | nucleoside phosphatase, putative |
Leishmania infantum | LinJ.10.0150 | nucleoside phosphatase, putative,guanosine diphosphatase, putative |
Leishmania infantum | LinJ.15.0030 | ATP diphosphohydrolase |
Leishmania major | LmjF.15.0030 | ATP diphosphohydrolase |
Leishmania major | LmjF.10.0170 | nucleoside phosphatase, putative,guanosine diphosphatase, putative |
Leishmania mexicana | LmxM.15.0030 | nucleoside diphosphatase, putative |
Leishmania mexicana | LmxM.10.0170 | nucleoside phosphatase, putative,guanosine diphosphatase, putative |
Mus musculus | ENSMUSG00000033068 | ectonucleoside triphosphate diphosphohydrolase 6 |
Mus musculus | ENSMUSG00000021236 | ectonucleoside triphosphate diphosphohydrolase 5 |
Neospora caninum | NCLIV_060550 | Ectonucleoside triphosphate diphosphohydrolase 2, related |
Oryza sativa | 4350421 | Os11g0440200 |
Oryza sativa | 4350420 | Os11g0439600 |
Oryza sativa | 4349645 | Os11g0126400 |
Oryza sativa | 4351367 | Os12g0123500 |
Oryza sativa | 4344315 | Os07g0682800 |
Saccharomyces cerevisiae | YEL042W | Gda1p |
Schistosoma japonicum | Sjp_0214380 | ko:K01511 nucleoside-diphosphatase [EC3.6.1.6], putative |
Schistosoma mansoni | Smp_081450 | adenosine diphosphatase |
Schmidtea mediterranea | mk4.003992.02 | |
Schmidtea mediterranea | mk4.010067.00 | |
Schmidtea mediterranea | mk4.000295.05 | Nucleoside-diphosphatase uda-1 |
Schmidtea mediterranea | mk4.001744.00 | |
Schmidtea mediterranea | mk4.003743.01 | |
Schmidtea mediterranea | mk4.002538.04 | |
Schmidtea mediterranea | mk4.003743.03 | |
Trypanosoma brucei gambiense | Tbg972.8.3510 | nucleoside phosphatase, putative,guanosine diphosphatase, putative |
Trypanosoma brucei gambiense | Tbg972.7.1920 | nucleoside diphosphatase, putative |
Trypanosoma brucei | Tb927.8.3800 | nucleoside phosphatase, putative |
Trypanosoma brucei | Tb927.7.1930 | nucleoside diphosphatase, putative |
Trypanosoma congolense | TcIL3000_0_35580 | nucleoside diphosphatase, putative |
Trypanosoma congolense | TcIL3000_8_3670 | nucleoside phosphatase, putative |
Trypanosoma cruzi | TcCLB.506229.50 | nucleoside phosphatase, putative |
Toxoplasma gondii | TGME49_307800 | GDA1/CD39 (nucleoside phosphatase) family protein |
Gene/Ortholog | Organism | Phenotype | Source Study |
---|---|---|---|
Tb927.8.3800 | Trypanosoma brucei | no significant loss or gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.8.3800 | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.8.3800 | Trypanosoma brucei | no significant loss or gain of fitness in procyclic forms | alsford |
Tb927.8.3800 | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
Tb927.7.1930 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (3 days) | alsford |
Tb927.7.1930 this record | Trypanosoma brucei | significant gain of fitness in bloodstream forms (6 days) | alsford |
Tb927.7.1930 this record | Trypanosoma brucei | significant loss of fitness in procyclic forms | alsford |
Tb927.7.1930 this record | Trypanosoma brucei | significant gain of fitness in differentiation of procyclic to bloodstream forms | alsford |
TGME49_307800 | Toxoplasma gondii | Essentiality uncertain | sidik |
gerdes | Experimental determination and system-level analysis of essential genes in E. coli MG1655 | Gerdes et al., J Bacteriol. 2003 185:5673-84 |
alsford | High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome | Genome Res 2011, 21:915-924 |
nmpdr | Genome-scale essentiality datasets from published studies (M. tuberculosis) | National Microbial Pathogen Data Resource |
shigen | Profiling of E. coli Chromosome (PEC) | National Institute of Genetics, Japan |
yeastgenome | Systematic deletion of yeast genes | Saccharomyces Genome Database |
wormbase | C. elegans RNAi experiments | WormBase web site, http://www.wormbase.org, release WS170 |
blattner | Systematic mutagenesis of the E. coli (MG1655) genome | J Bacteriol 2004, 186:4921-4930 |
neb | C. elegans RNAi phenotypes | Data obtained from Wormbase WS150, curated by K. Chaudary and T. Carlow, New England Biolabs |
keio | Systematic single-gene knock-out mutants of E. coli K12 | The Keio Collection |
Affected Entity | Phenotypic quality | Occurs in | Occurs at | Evidence | Observed in | Drugs/Inhibitors |
---|---|---|---|---|---|---|
cell proliferation (GO:0008283) | increased (PATO:0000470) | bloodstream stage trypomastigotes (PLO:0027) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in bloodstream forms (stage 6 days). | References: | 21363968 | |
cell proliferation (GO:0008283) | decreased (PATO:0000468) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | decreased cell proliferation (significant loss of fitness) in procyclic forms . | References: | 21363968 | |
cell proliferation (GO:0008283) | increased (PATO:0000470) | procyclic (PLO:0034) | inferred from RNAi experiment (ECO:0000019) | No drug identifiers listed for this gene. | ||
Annotator: | fernan@iib.unsam.edu.ar. | Comment: | increased cell proliferation (significant gain of fitness) in differentiation of procyclic to bloodstream forms . | References: | 21363968 |
In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.
In any case, if you have information about papers containing relevant validation data for this target, please contact us.
Species | Known druggable target | Linked compounds | Reference |
---|---|---|---|
Trypanosoma cruzi | nucleoside phosphatase, putative | Compounds | References |
1 literature reference was collected for this gene.